Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Timothy M. Shannon currently holds 1,674,788 shares of Celldex Therapeutics, Inc. (CLDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy M. Shannon has been a net seller of CLDX stock. They have purchased $6.1M and sold $41.4M worth of shares.
Timothy M. Shannon's most recent insider trade was on Sep 7, 2021, when they sold 14,751 shares at $87.98 per share.
Timothy M. Shannon serves as Executive at Celldex Therapeutics, Inc. (CLDX). They have executed 87 insider transactions totaling $47.6M over their tenure at the company.
Timothy M. Shannon holds the position of Executive at Celldex Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Timothy M. Shannon has shown a selling trading pattern, with $6.1M in total purchases and $41.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Timothy M. Shannon was on Aug 31, 2021, when they sold $4.0M worth of ARVN shares. This transaction involved 47,166 shares at $85.39 per share.
Timothy M. Shannon currently owns 1,674,788 shares of Celldex Therapeutics, Inc. (CLDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Timothy M. Shannon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Timothy M. Shannon has 87 Form 4 filings on record as an insider at Celldex Therapeutics, Inc..
Set alerts for Timothy M. Shannon and 40,000+ other insiders.